/ tempus ai
Tempus AI and CRISPR Therapeutics: The Twin Engines of Precision Medicine
Policy tailwinds and precision medicine breakthroughs are pushing healthcare stocks like Tempus AI and CRISPR Therapeutics into a new era of growth.
October 09, 2025Tempus AI, Inc. (NASDAQ: TEM) Reports Robust Q2 Results, Outperforms Expectations
Tempus AI, Inc. reported a strong second quarter in 2025 with revenue exceeding expectations and a narrowed net loss.
August 08, 2025